CFO Matt Steinfort sold $1.7M worth of DOCN at $170.07, reducing his stake by 1.8% while the stock traded just 3.9% below its 90-day high. This second substantial sale in three weeks totaling $5.5M suggests ongoing insider profit-taking despite strong analyst consensus. Bear: breaks $101 support; bull holds above $170 resistance.

Where it could go — No historical pattern data yet; broad base rate 0% positive at 90d for similar signals.

JENSON WARREN exercised 20,000 options at $19.47 and sold the resulting shares at $147.62 ($3.0M). The sale came from newly exercised options and did not reduce previously held shares, leaving 32,497 directly held shares.

Where it could go — Exercise-and-sell transactions are largely mechanical and carry limited directional signal.

CFO Matt Steinfort sold $3.8M worth of DOCN at $152.50, reducing his stake by 4.2% at a price just 5% below the 90-day high. This first-ever transaction by the CFO is a notable event, but its timing—not at a peak and without other officers selling—makes it ambiguous. Bear: a break below the 30-day low of $74.37 would confirm weakness; bull: holds above $152.50 with the STRONG BUY analyst consensus intact.

Where it could go — No similar DOCN signal history; broad base rate for first-time officer sells is negative at 90d. Bear breaks $74.37.

Director Hilary Schneider sold $678K in DOCN shares at $156.38, reducing her stake by 15.1% in her first-ever reported transaction. A director's inaugural sale is notable, but with no other insiders buying and the stock trading 206% above its 90-day low, this appears more like routine portfolio management than a distress signal.

Where it could go — Analyst mean target not provided; bear case if stock breaks below recent support near $74.37.